Results 71 to 80 of about 404,841 (308)

An Open-Label Observational Trial to Evaluate the Possible Effects of Individualized Homoeopathic Medicines in Symptomatic Nasal Polyp

open access: yesBengal Journal of Otolaryngology and Head Neck Surgery, 2019
Introduction: Nasal polyps presenting with chronic rhino-sinusitis (CRS) is a commonly encountered condition characterized by nasal obstruction, loss of sense of smell (anosmia), postnasal drip, headache, and sleep disorders.
Aniruddha Banerjee   +3 more
doaj   +3 more sources

The Roles of Autophagy, Mitophagy, and the Akt/mTOR Pathway in the Pathogenesis of Chronic Rhinosinusitis with Nasal Polyps

open access: yesJournal of Immunology Research, 2022
The pathogenesis of CRSwNP is complex and unclear. CRSwNP is subdivided into two types based on the infiltration of EOSs: eCRSwNP and noeCRSwNP. This study was designed to seek the role of autophagy, mitophagy, and Akt/mTOR pathway in these two subtypes ...
Chen Wang   +3 more
doaj   +1 more source

Antimicrobial and Defense Proteins in Chronic Rhinosinusitis with Nasal Polyps

open access: yesMedicina, 2023
Background and Objectives: Chronic rhinosinusitis with nasal polyps (CRSwNP) presently remains a difficult disease to manage. Antimicrobial and defense proteins are important factors that could help characterize the role of microorganisms in CRSwNP ...
Rudolfs Janis Viksne   +2 more
doaj   +1 more source

Inflammatory Septal Nasal Polyp.

open access: yesIranian journal of otorhinolaryngology, 2015
Nasal polyps are benign prolapsed mucosal lesions which commonly arise from the paranasal sinuses and lateral walls of the nose especially the contact areas of osteomeatal complex. Though nasal polyps arising from the nasal septum have been reported, those arising from its anterior part are extremely rare and present a diagnostic dilemma.
Ruchi Agarwal   +4 more
openaire   +4 more sources

Audit on the use of radiological investigations in the management of rhinosinusitis [PDF]

open access: yes, 2013
Objectives: The aim of this audit is to establish the cost to the Maltese health system from the use of radiological imaging in managing rhinosinusitis and to identify areas in which these costs can be minimised by following guidelines on the management ...
Borg-Xuereb, Hermann K.   +2 more
core  

Chronic rhinosinusitis with nasal polyps in older adults : clinical presentation, pathophysiology, and comorbidity

open access: yes, 2019
Purpose of Review Chronic rhinosinusitis and nasal polyps (CRSwNP) is a common condition that significantly affects patients' life. This work aims to provide an up-to-date overview of CRSwNP in older adults, focusing on its aging-related clinical ...
Bachert, Claus   +3 more
core   +2 more sources

Nasal decongestants in monotherapy for the common cold [PDF]

open access: yes, 2016
Background : Many treatments for the common cold exist and are sold over-the-counter. Nevertheless, evidence on the effectiveness and safety of nasal decongestants is limited.
De Sutter, An   +4 more
core   +2 more sources

Characterization of T-cell Subpopulations in Patients with Chronic Rhinosinusitis with Nasal Polyposis

open access: yesAllergy & Rhinology, 2017
Background There is an ongoing discussion concerning the potential origins of chronic rhinosinusitis with nasal polyposis (CRSwNP). Objective The aim of this study was to quantify subpopulations of T cells in peripheral blood and nasal polyps in CRSwNP ...
Pascal Ickrath M.D.   +7 more
doaj   +1 more source

Staphylococcus aureus controls interleukin-5 release in upper airway inflammation [PDF]

open access: yes, 2018
Staphylococcus aureus is a frequent colonizer of the upper airways in chronic rhinosinusitis with nasal polyps, but also resides intramucosally, it has been shown that secreted staphylococcal proteins such as enterotoxins and serine proteases induce the ...
Bachert, Claus   +11 more
core   +2 more sources

Omalizumab's effectiveness in severe allergic asthma and nasal polyps: a real-life study.

open access: yesJournal of investigational allergology & clinical immunology, 2020
BACKGROUND AND OBJECTIVE Omalizumab is a human anti-IgE antibody approved for the treatment of severe allergic asthma (SAA), but its effectiveness when a chronic rhinosinusitis with nasal polyposis (CRSNP+) is associated is less documented.
A. Tiotiu   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy